Increased out-of-pocket costs for antiepileptic drugs were associated with decreased adherence, higher healthcare utilization, and higher spending among US commercial health plan beneficiaries with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback